|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$82,998.76 |
2.76% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$82,572.91 |
2.75% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$80,347.35 |
2.67% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$76,882.60 |
2.56% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$73,911.09 |
2.46% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,386.90 |
2.44% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$71,819.58 |
2.39% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$69,819.30 |
2.32% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,586.96 |
2.32% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$68,347.40 |
2.27% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,339.56 |
2.24% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$66,546.20 |
2.21% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$66,494.88 |
2.21% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$65,275.20 |
2.17% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$65,322.37 |
2.17% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$65,270.09 |
2.17% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$64,976.62 |
2.16% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$64,096.42 |
2.13% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$63,553.10 |
2.12% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$63,506.78 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$63,243.48 |
2.10% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$61,093.26 |
2.03% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$60,659.40 |
2.02% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,590.60 |
2.02% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$60,612.82 |
2.02% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$60,526.80 |
2.01% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$60,079.05 |
2.00% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$59,343.75 |
1.98% |
| Steris Plc |
STE |
G8473T100 |
265 |
$58,599.45 |
1.95% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$58,112.04 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,628.80 |
1.92% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,888.80 |
1.89% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,560.32 |
1.88% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$56,486.56 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$55,560.26 |
1.85% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$55,098.90 |
1.83% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$53,576.86 |
1.78% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$53,219.54 |
1.77% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$53,019.90 |
1.76% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$52,753.32 |
1.76% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,957.42 |
1.76% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$52,302.90 |
1.74% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$52,312.08 |
1.74% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$50,930.15 |
1.70% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$49,329.00 |
1.64% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$46,407.99 |
1.54% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,350.53 |
1.51% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,612.10 |
1.42% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$41,737.03 |
1.39% |
| US Dollar |
$USD |
|
14,835 |
$14,834.64 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|